WCG and Deep 6 AI Announce Partnership


WCG and Deep 6 AI announced that they are working together to drive more targeted patient recruitment in clinical trials and accelerate enrollment in vital medical research. The relationship brings together WCG's market position, and their investigative sites, biopharma sponsors, CROs, and Deep 6 AI's software. As a result, WCG and Deep 6 AI's collaboration will enable clinical trials as a care alternative for more people and empower greater diversity among research participants.

Read more about this new partnership here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.